AMAlexandra Migasová

Alexandra Migasová

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra Migasová has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Anass Benziane

    Department of Biophysics and Cell Biology, Faculty of Medicine, Doctoral School of Molecular Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary

    1 shared publication
  • Andrea Bodnár

    Department of Biophysics and Cell Biology, Faculty of Medicine, Doctoral School of Molecular Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary

    1 shared publication
  • Andreas Walter

    Center for Optical Technologies, Aalen University, Anton-Huber-Straße 21, DE-73430 Aalen, Germany

    1 shared publication
  • Arpan Chowdhury

    Department of Biophysics and Cell Biology, Faculty of Medicine, Doctoral School of Molecular Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary

    1 shared publication
  • Erik Sedlák

    Center for Interdisciplinary Biosciences P. J. Šafárik University in Košice Košice Slovakia

    1 shared publication
  • Florina Zakany

    Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen and MTA Centre of Excellence, Hungarian Academy of Sciences, Egyetem tér 1, Debrecen H-4032, Hungary

    1 shared publication

Latest Publications

  • Open Access

    Hierarchical Functionalisation of UiO-66(Zr)-NH2 with Cysteine, PEG, and SARS-CoV-2 Spike RBD to Facilitate ACE2 Receptor Targeting in Model Cells

    by Veronika Huntošová, Saraa Baddour, Alexandra Migasová, Noémi Bilakovics, Anass Benziane, Michaela Salaková, Zuzana Jurašeková, Tomáš Zelenka, Gabriela Zelenková, Tim Schubert, et al.

    Hierarchical functionalisation of the UiO-66(Zr)-NH2 metal–organic framework with cysteine, poly(ethylene glycol) (PEG), and the SARS-CoV-2 spike receptor-binding domain (RBD) was developed to enable receptor-specific interaction with the angiotensin-converting enzyme 2 receptor (ACE2) in model cells. Post-synthetic modification using cysteine and heterobifunctional PEG linkers allowed controlled bioconjugation of SpyTag-labelled RBD via SpyTag/SpyCatcher chemistry, while preserving the crystallinity, microporosity, and intrinsic optical properties of the UiO-66(Zr)-NH2 framework. Comprehensive physicochemical characterisation confirmed successful surface functionalisation, tunable aggregation behaviour, and retention of multimodal optical characteristics. Cellular studies in HEK293T and HeLa cells overexpressing EGFP-tagged ACE2 demonstrated enhanced and selective association and uptake of RBD-functionalised nanoparticles compared with non-targeted analogues. Multimodal fluorescence imaging, fluorescence lifetime imaging microscopy, flow-cytometry, and electron microscopy indicated ACE2-dependent endocytic internalisation, with predominant localisation in endosomal and autophagosomal compartments, while both amine- and cysteine-modified formulations exhibited good biocompatibility. Overall, this study establishes a virus-mimetic, ACE2-targeted UiO-66(Zr)-based nanosystem as a proof-of-concept biointerface platform for receptor-specific cellular delivery and imaging, providing a foundation for future MOF-based nanocarriers exploiting ligand–receptor interactions.